Health Disparities in Peripheral Artery Disease: A Scientific Statement From the American Heart Association
Matthew Allison, David G. Armstrong, Philip P. Goodney, Naomi M. Hamburg, Lee Kirksey, Kristie J. Lancaster, Carlos Mena‐Hurtado, Sanjay Misra, Diane Treat‐Jacobson, Khendi White Solaru
Abstract
Peripheral artery disease (PAD) affects 200 million individuals worldwide. In the United States, certain demographic groups experience a disproportionately higher prevalence and clinical effect of PAD. The social and clinical effect of PAD includes higher rates of individual disability, depression, minor and major limb amputation along with cardiovascular and cerebrovascular events. The reasons behind the inequitable burden of PAD and inequitable delivery of care are both multifactorial and complex in nature, including systemic and structural inequity that exists within our society. Herein, we present an overview statement of the myriad variables that contribute to PAD disparities and conclude with a summary of potential novel solutions.